MIRA Pharmaceuticals (MIRA) Stock Chart & Stock Price History → get a piece of the profit from this land (From True Market Insiders) (Ad) Free MIRA Stock Alerts $0.66 -0.02 (-2.96%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media MIRA Pharmaceuticals Stock Price Performance5 Day Performance-11.28%1 Month Performance-21.24%3 Month Performance-37.02%6 Month Performance-80.27%Year-To-Date Performance-37.62% Receive MIRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. MIRA Stock Chart for Sunday, May, 19, 2024 MIRA Chart by TradingView MIRA Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$0.68$0.66-3.61%$0.71$0.6374,728 shs$9.68 million05/16/2024$0.71$0.68-4.34%$0.75$0.6488,546 shs$10.04 million05/15/2024$0.74$0.71-3.79%$0.73$0.7042,972 shs$10.50 million05/14/2024$0.72$0.74+2.96%$0.77$0.7158,266 shs$10.91 million05/13/2024$0.72$0.72-0.40%$0.77$0.7034,710 shs$10.60 million05/10/2024$0.75$0.72-4.00%$0.79$0.7175,914 shs$10.64 million Get the Latest News and Ratings for MIRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$0.76$0.75-1.30%$0.76$0.739,872 shs$11.09 million05/08/2024$0.76$0.76-0.01%$0.81$0.739,096 shs$11.23 million05/07/2024$0.75$0.76+1.33%$0.79$0.7316,077 shs$11.23 million05/06/2024$0.73$0.75+2.32%$0.80$0.7369,926 shs$11.09 million05/03/2024$0.80$0.79-1.95%$0.86$0.72324,318 shs$11.62 million05/02/2024$0.82$0.80-2.16%$0.84$0.8024,062 shs$11.85 million05/01/2024$0.85$0.82-3.61%$0.85$0.8021,365 shs$12.11 million04/30/2024$0.85$0.85$0.85$0.8214,866 shs$12.56 million04/29/2024$0.86$0.85-1.14%$0.89$0.8516,527 shs$12.56 million04/26/2024$0.90$0.86-4.47%$0.92$0.8512,549 shs$12.71 million04/25/2024$0.87$0.90+3.45%$0.90$0.8720,404 shs$13.30 million04/24/2024$0.88$0.87-0.92%$0.90$0.8513,077 shs$12.86 million04/23/2024$0.86$0.88+2.10%$0.90$0.8732,710 shs$12.98 million04/22/2024$0.83$0.86+3.42%$0.87$0.8521,644 shs$12.71 million04/19/2024$0.87$0.83-3.86%$0.86$0.7953,258 shs$12.29 million04/18/2024$0.81$0.87+6.82%$0.89$0.8017,217 shs$12.79 million04/17/2024$0.79$0.81+2.51%$0.91$0.7860,735 shs$11.97 million04/16/2024$0.83$0.79-4.82%$0.85$0.7663,940 shs$11.68 million04/15/2024$0.90$0.83-7.83%$0.90$0.8051,553 shs$12.27 million04/12/2024$1.00$0.90-9.83%$0.98$0.8875,968 shs$13.31 million04/11/2024$1.00$1.00-0.03%$1.01$0.9619,460 shs$14.76 million04/10/2024$1.02$1.00-2.06%$1.02$0.9648,394 shs$14.77 million04/09/2024$1.03$1.02-0.97%$1.04$1.0018,207 shs$15.08 million04/08/2024$1.02$1.03+0.98%$1.06$1.0128,526 shs$15.22 million04/05/2024$1.02$1.02$1.04$1.00102,637 shs$15.08 million04/04/2024$1.07$1.02-4.67%$1.09$1.0266,926 shs$15.08 million04/03/2024$1.07$1.07$1.07$1.0249,019 shs$15.82 million04/02/2024$1.08$1.07-0.93%$1.11$1.02157,991 shs$15.82 million04/01/2024$1.10$1.08-1.82%$1.12$1.0545,811 shs$15.96 million03/29/2024$1.10$1.10$1.18$1.09140,708 shs$16.26 million03/28/2024$1.09$1.10+0.92%$1.18$1.09140,628 shs$16.26 million03/27/2024$1.15$1.09-5.22%$1.18$1.07139,802 shs$16.11 million03/26/2024$1.16$1.15-0.86%$1.17$1.1137,681 shs$17.00 million03/25/2024$1.23$1.16-5.69%$1.27$1.1563,892 shs$17.15 millionThe Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now.03/22/2024$1.26$1.23-2.38%$1.27$1.2077,373 shs$18.18 million03/21/2024$1.24$1.26+1.61%$1.44$1.20236,641 shs$18.62 million03/20/2024$1.19$1.24+4.20%$1.28$1.15138,912 shs$18.33 million03/19/2024$1.18$1.19+0.85%$1.21$1.13107,148 shs$17.59 million03/18/2024$1.18$1.18$1.22$1.12156,532 shs$17.44 million03/15/2024$1.23$1.18-4.07%$1.23$1.05236,300 shs$17.44 million03/14/2024$1.10$1.23+11.82%$1.30$1.04543,307 shs$18.18 million03/13/2024$1.55$1.10-29.03%$1.59$1.04714,814 shs$16.26 million03/12/2024$1.50$1.55+3.33%$1.68$1.421.07 million shs$22.91 million03/11/2024$1.57$1.50-4.46%$1.84$1.403.68 million shs$22.17 million03/08/2024$0.92$1.57+71.40%$1.57$1.1825.94 million shs$23.21 million03/07/2024$0.96$0.92-4.08%$0.96$0.92749,089 shs$13.54 million03/06/2024$0.93$0.96+2.69%$0.99$0.9144,167 shs$14.12 million03/05/2024$0.99$0.93-6.06%$1.01$0.9187,018 shs$13.75 million03/04/2024$1.04$0.99-4.80%$1.02$0.9730,017 shs$14.63 million03/01/2024$1.01$1.04+3.47%$1.04$0.9837,692 shs$15.37 million02/29/2024$1.00$1.01+0.50%$1.05$0.9670,314 shs$14.85 million02/28/2024$1.05$1.00-4.76%$1.04$1.0018,618 shs$14.78 million02/27/2024$1.03$1.05+1.94%$1.10$1.0040,650 shs$15.52 million02/26/2024$1.00$1.03+3.00%$1.06$0.9533,254 shs$15.22 million02/23/2024$1.06$1.00-5.66%$1.06$0.8559,028 shs$14.78 million02/22/2024$1.08$1.06-1.85%$1.10$1.0334,935 shs$15.67 million02/21/2024$1.07$1.08+0.93%$1.10$1.0434,355 shs$15.96 million02/20/2024$1.04$1.07+2.88%$1.12$1.0383,692 shs$15.82 million02/19/2024$1.04$1.04$1.13$1.0369,900 shs$15.37 million Related Companies: Moleculin Biotech Stock Chart Akari Therapeutics Stock Chart ABVC BioPharma Stock Chart Molecular Templates Stock Chart Elevai Labs Stock Chart Eterna Therapeutics Stock Chart Guardion Health Sciences Stock Chart Avalo Therapeutics Stock Chart Aeterna Zentaris Stock Chart Galera Therapeutics Stock Chart Receive MIRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MIRA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.